Abstract: In Parkinson's disease (PD), there is a putative delay between the onset of the neurodegenerative process, marked by the death of dopamine-producing cells, and the onset of hallmark motor symptoms, creating an urgent need to develop biomarkers that may yield early PD detection. Neuroimaging offers a non-invasive approach to examine the utility of a vast number of functional and structural brain characteristics as biomarkers. We present a statistical framework for analyzing neuroimaging data from multiple modalities to determine features that reliably distinguish PD patients from healthy control subjects. This pursuit involves precision discovery from ultra-high dimensional data. Our approach builds on the statistical learning procedure elastic net, performing regularization and variable selection, while introducing additional criteria centering on parsimony and reproducibility. We apply our methods to data from two studies of PD. We demonstrate high accuracy, assessed via cross-validation, and identify brain regions in the basal ganglia and outer cortex that are implicated in the neurodegenerative PD process.
Wednesday, February 26, 2020
Udall Parkinson’s Disease Research Update - Presented by F. DuBois Bowman, PhD, Dean, School of Public Health and Professor of Biostatistics - Wednesday, February 26th, 2020
12:30 PM to 1:30 PM
Undergraduate Science Building, Room 4130, 204 Washtenaw Ave, Ann Arbor, MI 48109
Precision Discovery of Neuroimaging Biomarkers for Parkinson's Disease